Non-radiographic axial spondyloarthritis localized to the occipito-atlanto-axial region — the articulations between the occiput, atlas (C1), and axis (C2) — where active inflammation is confirmed by MRI or clinical criteria but plain radiographs show no definitive structural damage.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 7
- Region
- Spine
Documentation tips
What should appear in the chart to support M45.A1.
Source · Editorial brief grounded in 6 cited references ↓
- Record the specific spinal region by name — 'occipito-atlanto-axial region' or 'craniocervical junction' — so the site-specific code M45.A1 is defensible over the unspecified parent M45.A0.
- Document that plain radiographs of the SI joints and the affected spinal region do NOT show definitive structural damage; this is the core criterion separating nr-axSpA from AS (M45.1).
- Include MRI findings for the occipito-atlanto-axial region and/or sacroiliac joints — bone marrow edema, synovitis, enthesitis — as positive imaging supports medical necessity when X-rays are negative.
- Note HLA-B27 status and CRP/ESR results; elevated inflammatory markers and positive HLA-B27 strengthen the nr-axSpA diagnosis and support payer review.
- Capture inflammatory back pain characteristics: insidious onset before age 45, improvement with activity but not rest, morning stiffness >30 minutes. These clinical criteria are payer-audited for biologics.
- If the patient has a prior code of M46.8 (other specified inflammatory spondylopathy) from before FY2022, flag the transition to M45.A1 in the problem list for continuity and data integrity.
Related CPT procedures
Procedure codes commonly billed with M45.A1. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M45.A1 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M45.1 (ankylosing spondylitis of occipito-atlanto-axial region) when radiographic damage is absent — M45.1 requires radiographic evidence; without it, M45.A1 is the correct code.
- Defaulting to the unspecified parent M45.A0 when the physician has documented a specific spinal region; M45.A1 is billable and more specific, reducing audit risk.
- Coding M46.8 for nr-axSpA in encounters dated on or after October 1, 2021 — the dedicated M45.A subcategory superseded that practice.
- Applying M45.A1 when the patient has juvenile onset — M08.1 (juvenile ankylosing spondylitis) is required by the Excludes1 note at the M45 category level.
- Combining M45.A1 with M02.3- (Reiter's disease arthropathy) or M35.2 (Behçet's disease) in the same encounter — both are blocked by the category-level Excludes notes.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M45.A1 applies when a rheumatologist has diagnosed non-radiographic axial spondyloarthritis (nr-axSpA) and the documented disease site is the occipito-atlanto-axial region. The defining feature is the absence of definitive radiographic damage on plain X-ray despite active inflammatory findings — typically MRI-confirmed sacroiliitis or positive HLA-B27 with inflammatory back pain. This distinguishes nr-axSpA from ankylosing spondylitis (AS), which requires radiographic evidence of structural damage. The parallel AS code for this same spinal region is M45.1.
Nr-axSpA at the occipito-atlanto-axial level presents with upper cervical pain and stiffness that follows the inflammatory pattern: worse at rest, improved with activity, often with morning stiffness exceeding 30 minutes. Unlike peripheral arthritis, it is driven by enthesitis and synovitis in the craniocervical junction. The condition shares features with AS — HLA-B27 association, potential peripheral arthritis, uveitis, IBD — but without radiographic sacroiliitis, and it affects men and women roughly equally.
This code sits under parent M45.A (non-radiographic axial spondyloarthritis, unspecified site) and was introduced as a new code effective October 1, 2021, giving nr-axSpA its own site-specific taxonomy separate from the legacy catch-all M46.8. The Excludes1 notes at the M45 category level bar simultaneous use with M02.3- (Reiter's disease arthropathy) and M08.1 (juvenile ankylosing spondylitis); the Excludes2 note bars simultaneous use of M35.2 (Behçet's disease).
Sibling codes
Other billable codes under M45.A (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What is the difference between M45.A1 and M45.1?
02When was M45.A1 introduced, and why does it matter?
03Can I use M45.A1 if the patient also has Behçet's disease?
04What if the rheumatologist documents nr-axSpA but doesn't specify a spinal region?
05Is M45.A1 appropriate for juvenile patients?
06Which MS-DRGs does M45.A1 map to?
07Does M45.A1 require a 7th character extension?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M45-M49/M45-/M45.A1
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M45.A1
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M45.A
- 05creakyjoints.orghttps://creakyjoints.org/about-arthritis/diagnosis/non-radiographic-axial-spondyloarthritis-icd-10-diagnostic-code/
- 06spondylitis.orghttps://spondylitis.org/spondylitis-plus/what-is-non-radiographic-axial-spondyloarthritis/
Mira AI Scribe
Mira AI Scribe captures the spinal region (occipito-atlanto-axial), radiographic findings (negative X-ray, MRI inflammation status), HLA-B27 result, CRP/ESR values, and inflammatory back pain characteristics from the clinical note. This prevents downcoding to the unspecified M45.A0, misassignment to the AS code M45.1, or carry-forward use of the legacy M46.8 — all of which create payer audit exposure for biologic authorization.
See how Mira captures M45.A1 documentation